F&G Annuities & Life, a major insurance provider, will announce its third quarter 2026 earnings after market close on November 5, 2026. The company will host a webcast and conference call at 9:00 a.m. Eastern Time on November 6 to discuss the results. Investors can access the event live via F&G's Investor Relations website or by phone. This earnings report will provide insights into F&G's recent financial performance and outlook.
F&G Annuities & Life's upcoming Q3 2026 earnings announcement provides context for financial sector activity on Pluang. As of Oct 06, 2026 02:42 WIB, 60 of 85 Financials-sector US stocks on Pluang rose while 24 fell. Notable movers include WULF at USD 14.81 with a 1-day change of -4.39%, SAN at USD 13.90 up 4.08%, and COIN at USD 188.88 up 3.21%.
Revvity's stock has surged 56.1% year-to-date, outperforming its industry and the S&P 500, driven by an 11% organic revenue growth in diagnostics, especially in reproductive health and immunodiagnostics. Analysts from William Blair and Zacks have upg...
Levi Strauss & Co. is set to report its Q3 2026 earnings on October 7, with analysts forecasting adjusted earnings of $0.36 per share and revenue of $1.61 billion, marking a 4.5% increase year-over-year. Strong denim demand and growth in Europe, Asia...
On October 5, 2026, five notable stocks experienced double-digit declines. Sphere Entertainment fell 13.6% after a downgrade from Craig-Hallum, while C.H. Robinson dropped 10.9% following its announcement to acquire RXO for $5.8 billion. Velo3D, Boos...
Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...
Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...
